Gene and Protein Expression Profiling During Differentiation of Neuroblastoma Cells Triggered by 13-cis Retinoic Acid

Purpose The precise changes in RNA and protein expression that accompany neuroblastoma differentiation remain unknown. The authors used microarray technologies to screen molecules associated with the differentiation of neuroblastoma (NB) cells induced by 13-cis retinoic acid. Methods The authors quantified the expression of 2,061 RNA transcripts related to oncogenesis and of 380 proteins expressed in SK-N-SH and CHP-134 NB cell lines in the presence or absence of 13-cis retinoic acid. Results Hierarchical clustering captured gene expression altered during neuroblastoma differentiation induced by 13-cis retinoic acid. Several genes were further abstracted based on P values below 0.0017 or protein chips observed in both NB cell lines. The altered expressions of gene products revealed by both DNA and protein chips were in agreement. The expressions of N-myc, cyclin D3, and Wnt10B were downregulated, whereas those of retinoblastoma (RB) and related genes (p107, RB2/p130, p300/CBP, E2F-1, DP-1) as well as others were upregulated. Conclusions These results suggest that microarray technology can screen for genes that are important in neuroblastoma differentiation.

[1]  K. Wagner,et al.  The Wilms' tumor suppressor Wt1 is associated with the differentiation of retinoblastoma cells. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[2]  K. Ohnuma,et al.  Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  John Calvin Reed,et al.  Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. , 1991, Cancer research.

[4]  A. Giordano,et al.  RB2/p130 ectopic gene expression in neuroblastoma stem cells: evidence of cell-fate restriction and induction of differentiation. , 2001, The Biochemical journal.

[5]  M. Haussler,et al.  Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines. , 1983, Experimental cell research.

[6]  M. Israel,et al.  Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma , 1985, Nature.

[7]  K. Alitalo,et al.  The Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent manner , 2000, Oncogene.

[8]  I. Screpanti,et al.  Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status , 2000, British Journal of Cancer.

[9]  M. Baccarani,et al.  Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. , 2002, The New England journal of medicine.

[10]  R. Eisenman,et al.  N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. , 2002, Genes & development.

[11]  W. Sadee,et al.  Expression of neurotransmitter receptors and myc protooncogenes in subclones of a human neuroblastoma cell line. , 1987, Cancer research.

[12]  P. Moorhead,et al.  Establishment and characterization of human neuroblastoma cell lines. , 1976, Cancer research.

[13]  K. Matthay,et al.  Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  B. Bernardi,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1999.0855 , 2022 .

[15]  J. Ávila,et al.  Phosphorylation of microtubule-associated proteins by protein kinase CK2 in neuritogenesis. , 1994, Cellular & molecular biology research.

[16]  C. W. Scott,et al.  Casein kinase II preferentially phosphorylates human tau isoforms containing an amino-terminal insert. Identification of threonine 39 as the primary phosphate acceptor. , 1994, The Journal of biological chemistry.

[17]  Pediatric Oncology, , 2022 .

[18]  J Pritchard,et al.  Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992. , 2000, European journal of cancer.

[19]  A. Zantema,et al.  Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells , 1995, The Journal of cell biology.

[20]  F. Hakuno,et al.  Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway. , 2000, Endocrine journal.

[21]  P. Crespo,et al.  Ras proteins in the control of the cell cycle and cell differentiation , 2000, Cellular and Molecular Life Sciences CMLS.

[22]  B. Spengler,et al.  Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. , 1973, Cancer research.

[23]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[24]  A. Giordano,et al.  The RB-related gene Rb2/p130 in neuroblastoma differentiation and in B-myb promoter down-regulation , 1998, Cell Death and Differentiation.

[25]  J. Satoh,et al.  Beta-catenin expression in human neural cell lines following exposure to cytokines and growth factors. , 2000, Neuropathology (Kyoto. 1993).

[26]  J. Villablanca,et al.  Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation , 1996, Cancer Chemotherapy and Pharmacology.

[27]  M. Pfahl,et al.  Retinoic Acid Receptor γ1 (RARγ1) Levels Control RARβ2 Expression in SK-N-BE2(c) Neuroblastoma Cells and Regulate a Differentiation-Apoptosis Switch , 1998, Molecular and Cellular Biology.

[28]  H. Blau,et al.  RIP2, a Checkpoint in Myogenic Differentiation , 2002, Molecular and Cellular Biology.

[29]  J. Satoh,et al.  β‐Catenin expression in human neural cell lines following exposure to cytokines and growth factors , 2000 .

[30]  H. Avraham,et al.  NRP/B, a Novel Nuclear Matrix Protein, Associates With p110RB and Is Involved in Neuronal Differentiation , 1998, The Journal of cell biology.

[31]  H. Kirikoshi,et al.  Expression and regulation of WNT10B in human cancer: up-regulation of WNT10B in MCF-7 cells by beta-estradiol and down-regulation of WNT10B in NT2 cells by retinoic acid. , 2002, International journal of molecular medicine.

[32]  C. Redies,et al.  N‐ and R‐cadherin expression in the optic nerve of the chicken embryo , 1993, Glia.

[33]  F. Locatelli,et al.  Immunotherapy with low-dose recombinant interleukin 2 after high-dose chemotherapy and autologous stem cell transplantation in neuroblastoma. , 1998, British Journal of Cancer.

[34]  M. G. Paggi,et al.  Retinoblastoma family proteins induce differentiation and regulate B-myb expression in neuroblastoma cells. , 2001, Medical and pediatric oncology.

[35]  K. Y. Kim,et al.  The protective role of HSP90 against 3-hydroxykynurenine-induced neuronal apoptosis. , 2001, Biochemical and biophysical research communications.

[36]  A. M. Stanley,et al.  Structure of the extracellular region of HER 2 alone and in complex with the Herceptin Fab , 2022 .

[37]  J. Massagué,et al.  Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation , 1990, Cell.

[38]  J. Derry,et al.  RIP4 Is an Ankyrin Repeat-Containing Kinase Essential for Keratinocyte Differentiation , 2002, Current Biology.

[39]  L. Neckers,et al.  Retinoic acid decreases targeting of p27 for degradation via an N-myc-dependent decrease in p27 phosphorylation and an N-myc-independent decrease in Skp2 , 2003, Cell Death and Differentiation.

[40]  J. Kohler,et al.  A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy , 2000, British Journal of Cancer.

[41]  N. L. Thangue,et al.  Regulation of E2F transcription by cyclin E–Cdk2 kinase mediated through p300/CBP co-activators , 2000, Nature Cell Biology.

[42]  K. Murphy,et al.  MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cells , 2001, British Journal of Cancer.

[43]  M. Landry,et al.  Galanin and galanin receptor expression in neuroblastic tumours: correlation with their differentiation status , 2002, British Journal of Cancer.

[44]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[45]  M. Schwab,et al.  MycN sensitizes neuroblastoma cells for drug-triggered apoptosis. , 2000, Medical and pediatric oncology.